In most epithelial cells, COX-2 is absent or expressed at low levels but is a major contributor to inflammation and is up-regulated in many cancers, [20], so it is a relevant therapeutic target for cancer prevention and treatment [10,11,12,13]. The gene discussed is PTGS2; the disease is cancer.